Pharma Sessions

In this episode of Pharma Sessions, host Jonathan Kaskey speaks with Lars Dreesmann, the President and Site Head for Boehringer Ingelheim Fremont about how regulatory affairs can impact patient care.

They explore the challenges and opportunities in the regulatory space, including the impact of technology and AI on regulatory affairs and the potential for collaboration between pharmaceutical companies. 

Lars shares...

This episode is sponsored by Acceleration Point.

 Pharma Sessions is hosted by Jonathan Kaskey

In this episode Jonathan and Scott Thompson, the Co-CEO of Acceleration Point, discuss the impact of Artificial Intelligence (AI) on Medical Affairs. 

Examples of AI use in Medical Affairs include analytics, content creation, and productivity enhancements. 

Scott encourages experimentation with secure, customized AI tools to improve...

Life is different at a biotech. But is that a good thing?

Like so much in life, the answer is, "it depends."

On this episode I speak with Orlando Granado-Balaez about his journey from being a nurse to transitioning into medical affairs and ultimately thriving in smaller pharmaceutical companies. 

He shares his experiences in different roles within medical affairs, including being the first MSL i...

The Science of Sleep: Exploring its Role in Performance and Well-being for Medical Affairs

In this episode of Pharma Sessions, Jonathan Kaskey is joined by Dr. Alison Kole, a sleep expert, to discuss the importance of sleep and its impact on personal and professional health. 

They discuss the dangers of insufficient and poor-quality sleep, including poor cognitive and creative function. 

On the other hand...

In this compelling episode of Pharma Sessions, host Jonathan Kaskey engages in an insightful discussion with esteemed guest Jose Borbolla-Escoboza. Delving into the intricacies of global launch excellence, Jose, a seasoned oncologist, shares his wealth of experience in pharmaceuticals, particularly in Mexico, the UK, and the US. 

Together, they explore the multifaceted process of global launch preparation and the crucial r...

In this episode of "Pharma Sessions," host Jonathan Kaskey delves into the crucial topic of why negotiation skills are essential in the field of medical affairs. 

Joining him, Megan Vignos, Head of Scientific and Value Communications for US Medical at Biogen.

Together, they explore the importance of negotiation in medical affairs, and how a scientific mindset can aid in building effectiveness. 

...

In this episode of Pharma Sessions, host Jonathan Kaskey interviews Dr. Huma Qamar, Head of Clinical Development and Medical Affairs at Ocugen, Inc.

With her extensive background in clinical research and medicine, Dr. Qamar has been a pioneer in merging these two fields. Throughout this episode, she shares her invaluable insights on gene therapy, specifically focusing on inherited retinal diseases. Here are the top five th...

Join host Jonathan Kaskey in this thought-provoking episode of Pharma Sessions as he invites special guest Denise Bronner, Director of Clinical Trial Diversity and Inclusion at Janssen, to delve into critical issues facing the pharmaceutical industry.

Together, they explore the challenges of data sharing, the underrepresentation of non-white individuals in clinical trials, and the need for more inclusive physician training...

In this episode, host Jonathan Kaskey invites Patrina Pellet to discuss effective time management strategies for medical professionals. 

From calendar audits to time blocking, Pellet shares valuable insights on how to optimize your daily schedule, prioritize your tasks and avoid feeling burnt out. 

Discover the power of color-coding and task tracking to manage your workload efficiently and achieve your goals. 

We are excited to bring you the latest episode of our podcast series where we tackled the vital role of medical information in the healthcare industry.

Tim Fish is the Sr. Director of Medical Information, Knowledge Management, Med/Promo Review, Scientific Training & Development at Alkermes.

Tim has been in the medical information role for 15 years and shared valuable insights on the importance of receiving and respondin...

This episode is the second in Pharma Sessions' series of conversations about clinical trial diversity. The first episode was with a former pharma executive turned clinical trial consultant. In this episode we share a different, more community oriented perspective.

Renarda Jones is a clinical trial professional with over 20 years’ experience in clinical research., mainly in Cancer and Alzheimer’s disease research.

Starting as a r...

In Today’s episode Tom Caravela and I explore the question–what does a perfect MSL organization to support a product launch look like?

I’ve knonw Tom for years, and asked him to share his unique perspective on field medical organizations.

In addition to being a certified speaker, trainer and coach as well as a podcaster, Tom is the founder of an Executive Search Firm called The Carolan Group. They’re known for their niche expertise f...

Steve Royle is an innovative pharmaceutical professional with experience in both the commercial and medical affairs sides of the industry.  After starting in sales and marketing, Steve moved to the agency side of global medical communications and medical education. He went on to found Swipe Health and Rumi. Recently, Steve has used his expertise to create mymedicalafairs.com, a Netflix-style database of medical affairs events and t...

Camille Pope is the Chief Medical Lead at Acclinate, helping pharmaceutical companies and healthcare organizations access and engage communities of color so research is more inclusive.

She'd previously worked for several large pharmaceutical companies in both field medical and medical affairs leadership roles.

We discuss the importance of diversity in clinical trials, the new FDA guidance, the impacts that a lack of tr...

Chris Caudle is a LinkedIn specialist for execs working in the healthcare and life sciences sectors. He helps clients to develop their personal brand, increase their visibility, leadership and reach bigger audiences using LinkedIn as their launchpad.

In this episode Chris talks about how to use social media, specifically LinkedIn. He discusses the benefits of having a strong online brand and how to make it stand out.

Chris and Jon ta...

Evan Reddick recently joined an exciting emerging biotech with a major phase 3 trial win, and preparing to launch a first-in-class oral medication for breast cancer, serving as the AVP and Head of Global Medical Affairs Strategy. 

Evan previously had a number of field and leadership roles at a large pharma.

A highlight was the very first topic discussed, the framework of “Standing in Success”, and what that means for leaders. But we ...

Riad Dirani is the VP of Global HEOR at Teva Pharmaceuticals. 

We talk about: 

• Customizing data for a global audience
• The importance of a clear medical story
• How to create an insights gathering process that turns a scientific narrative into a living document
• How HEOR can best support a field team
• Involving Medical Directors in RWE generation
• What's needed to create "1 medical team" as a mindset
• What the future holds for ...

 Amber Spierer is the VP of Patient Affairs at EQRx, formally head of US Patient Engagement at Novartis.

We talk about: 

• Defining the patient journey
• Why understanding this journey is important strategically
• The difference between viewing someone as a patient and as a person
• Current patient expectations around working with pharma
• Tactics

The views expressed here are mine and Amber’s, and don’t reflect those of our employers.

Pharm...